Bharat Biotech’s Nasal vaccine has been approved|Know 5 Facts about it

Last Updated on January 11, 2023 by Dr Bucho

Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.

nasal vaccine free press journal edited
Image: Twitter[Freepress Journal]

New Delhi: Bharat Biotech’s nasal vaccine has been authorized as a booster dose, according to Health Minister Dr. Mansukh Mandaviya. The intranasal Covid vaccination from Bharat Biotech will be offered in private facilities and will be unveiled on CoWIN App on Friday night.

“The nasal vaccine has received government approval in India. It will be made first available in private hospitals and utilised as a heterologous booster. From today, it will be a part of the Covid vaccination programme “reputable sources stated.

India Today
India Today

Here is a Quick guide to the Nasal vaccine in 5 points:

  1. This evening, iNCOVACC, a two-drop nasal vaccination developed in India, will be unveiled on the Co-WIN platform.
  2. The vaccine, produced by Bharat Biotech, is now solely accessible at private facilities.
  3. The nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin.
  4. In heterologous boosting, a different vaccination from the one used for the initial dosage series was delivered.
  5. The Drugs Controller General of India approved the needle-free vaccine in November for constrained use in an emergency.

Bharat Biotech

According to Bharat Biotech, 4,000 volunteers in clinical studies showed an immunological response to the BBV154 vaccine, demonstrating its safety. The thin membranes that cover the nose, mouth, and lungs are the focus of mucosal vaccinations. They are supplied as drops, sprays, or capsules that are ingested into contact with the linings of the body’s barrier organs.

Frequently Asked Questions

How is Nasal Vaccine Given?

However, mucosal vaccines mad by other different countries is inhaled through the nose and mouth, while India’s intranasal coronavirus vaccine is administered as drops in the nose.

What is the Nasal vaccine made up of?

BBV154 is made from adenovirus, a relative in the family of cold viruses that expresses the spike protein found in SARS-CoV-2, which the virus uses to enter and infect the cells

When will Nasal Vaccine be Available in India?

From today 23 December 2022, it will be a part of the Covid vaccination program “reputable sources stated.

Thanks for reading 5 covid-19 safety gadgets and Thanks for visiting Dr Bucho , Get the latest updates, Blog Posts, FoodwellnessMental Healthnews, Alerts, admissions, and latest posts on our website, and stay up to date with us and don’t forget to check our page Student forum, where we have some free tools for medical professionals and students

covid-19 safety gadgets

Disclaimer: Please be aware that this material is being made solely for informational purposes. It makes no claims to be able to diagnose or treat any medical problem. Before making any changes, please speak with your doctor if you have any concerns about your health.

Scroll to Top